EFFECTS OF LONG-TERM ROUX-EN-Y GASTRIC BYPASS ON BODY WEIGHT AND CLINICAL METABOLIC COMORBIDITIES IN BARIATRIC SURGERY SERVICE OF A UNIVERSITY HOSPITAL.

Autor:	Silva CF; Bariatric Surgery Program, Clementino Fraga Filho Hospital, Federal University of Rio de Janeiro.; Josué de Castro Nutrition Institute, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Cohen L; Bariatric Surgery Program, Clementino Fraga Filho Hospital, Federal University of Rio de Janeiro., Sarmento LD; Bariatric Surgery Program, Clementino Fraga Filho Hospital, Federal University of Rio de Janeiro., Rosa FM; Bariatric Surgery Program, Clementino Fraga Filho Hospital, Federal University of Rio de Janeiro., Rosado EL; Josué de Castro Nutrition Institute, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Carneiro JR; Bariatric Surgery Program, Clementino Fraga Filho Hospital, Federal University of Rio de Janeiro., Souza AA; Bariatric Surgery Program, Clementino Fraga Filho Hospital, Federal University of Rio de Janeiro., Magno FC; Bariatric Surgery Program, Clementino Fraga Filho Hospital, Federal University of Rio de Janeiro.; Josué de Castro Nutrition Institute, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Jazyk:	English; Portuguese
Zdroj:	Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery [Arq Bras Cir Dig] 2016; Vol. 29Suppl 1 (Suppl 1), pp. 20-23.
DOI:	10.1590/0102-6720201600S10006
Abstrakt:	Background: Due to the high failure rate observed in the clinical treatment of morbid obesity an increase in bariatric surgery indications, as an alternative for the control of obesity and comorbidities, is noticeable. Aim: To evaluate the performance of type 2 diabetes mellitus, high blood pressure and dyslipidemia in patients submitted to Roux-en-Y gastric bypass in late follow-up. Methods: Retrospective analysis of 59 patients included in the bariatric surgery program. Anthropometric (height and body weight) and laboratory (LDLc, HDLc, VLDLc, triglyceride -TG - and glucose) data were collected on pre- and postoperative stages, through medical records. Results: Among the patients, 86% were female aged 43±11, of whom 52% had attended high school. The average postoperative time was 7±3 years. During the postoperative period, there were decreases of weight and body mass index, respectively (133±06 kg vs 91±04 kg p<0.05 e 49±74 kg/m2 vs 33±79 kg/m2, p<0.05). In comparison to the preoperative stage, lower concentrations of glucose (101.00±26.99 vs 89,11±15.19, p=0.014), total cholesterol rates (179.00±37,95 vs 167.48±28,50, p=0.016), LDLc (104.30±33.12 vs 91.46±24.58, p=0.016), VLDLc (25.40±11,12 vs 15.68±7.40, p<0.01), and TG (143.35±86.35 vs 82.45±37.39, p<0.01) and higher concentrations of HDLc (43.53±8.23 vs 57.90±15.60, p<0.01) were identified in the postoperative stage. 40% of hypertensive patients were still undergoing high blood pressure treatment during the postoperative stage. There was remission of type 2 diabetes mellitus and dyslipidemia on 81% and 94% of the cases, respectively. Conclusion: Roux-en-Y gastric bypass has proven itself to be an effective long term procedure, promoting weight loss, remission of DM2 and dyslipidemia. Competing Interests: none
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu